The Hepatitis C Treatment Study in Iran is one of the most important research studies conducted by the Digestive Diseases Research Institute (DDRI) which resulted in an important achievement with regards to the definitive treatment of hepatitis C in the country and the survival of hundreds of patients

The study of “Polypill” is one of the most important studies conducted at the Digestive Diseases Research Institute (DDRI), which resulted in the production of an effective drug for the prevention of heart attacks and brain stroke.

Complete achievement of the goals in the Golestan Cohort Study prompted a new effort, which was the formation of a large, prospective, population-based study with the collaborative participation of medical universities on a population of 200,000 Iranian from all races and ethnicities, named the Persian Cohort Study

The Golestan Cohort Study, which is considered the largest cohort study in the Middle East and North Africa, is a part of the Esophageal Malignancy Study in Northern Iran (GEMINI) and one of the most important medical research projects in Iran